As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.
Targeted on four priorities identified by the WHO : 1) epidemiological and translational studies; 2) the pathophysiology of the disease (not including vaccines); 3) infection prevention and control measures in the healthcare setting (including the
Agency or Funder
French Agence Nationale de la Recherche
Eligibility (if available)
Scientists from research institutes/organizations or company with French headquarters